A comparison of heart failure patients with reduced ejection fraction in the Moravian Midlands Registry with the LCZ696 patients in the Paradigm-HF trial.

Pavlu, Ludek; Vicha, Marek; Flasik, Jakub; Petrkova, Jana; Taborsky, Milos; Kacirkova, Tereza; Holy, Ondrej

Pavlu, Ludek; Vicha, Marek; Flasik, Jakub; Petrkova, Jana; Taborsky, Milos; Kacirkova, Tereza; Holy, Ondrej.

Affiliation

Pavlu L; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Vicha M; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Flasik J; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Petrkova J; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Taborsky M; Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
Kacirkova T; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Holy O; Science and Research Centre, Faculty of Health Sciences, Palacky University Olomouc, Olomouc, Czech Republic.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub ; 2023 Feb 06.

Article in En | MEDLINE | ID: mdl-36748670

Key words

MMR; Paradigm HF; heart failure; heart failure with reduced ejection fraction; registry; sacubitril-valsartan; treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Czech Republic Country of publication: Czech Republic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google